Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of "Moderate Buy" from Brokerages

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $57.40.

ESTA has been the subject of a number of research analyst reports. Stephens restated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. Needham & Company LLC began coverage on Establishment Labs in a research report on Monday, April 14th. They set a "hold" rating for the company.

Establishment Labs Trading Up 4.2 %

NASDAQ:ESTA traded up $1.27 during trading hours on Monday, hitting $31.45. The company had a trading volume of 558,088 shares, compared to its average volume of 453,840. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs has a 52 week low of $26.56 and a 52 week high of $60.12. The company has a market capitalization of $907.21 million, a PE ratio of -12.19 and a beta of 0.77. The stock has a 50-day moving average price of $36.56 and a 200 day moving average price of $39.72.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million for the quarter, compared to analysts' expectations of $44.45 million. On average, equities research analysts predict that Establishment Labs will post -2.41 EPS for the current fiscal year.

Hedge Funds Weigh In On Establishment Labs

Several large investors have recently modified their holdings of the stock. Brown Advisory Inc. increased its stake in Establishment Labs by 23.1% during the 4th quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock valued at $107,729,000 after purchasing an additional 438,057 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of Establishment Labs by 29.3% in the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock worth $88,064,000 after purchasing an additional 433,484 shares in the last quarter. Findell Capital Management LLC raised its stake in shares of Establishment Labs by 28.5% in the fourth quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock worth $62,032,000 after purchasing an additional 298,380 shares during the last quarter. William Blair Investment Management LLC lifted its holdings in shares of Establishment Labs by 44.1% during the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock valued at $37,447,000 after purchasing an additional 248,888 shares in the last quarter. Finally, Bamco Inc. NY increased its holdings in Establishment Labs by 53.8% in the 4th quarter. Bamco Inc. NY now owns 752,886 shares of the company's stock worth $34,685,000 after buying an additional 263,500 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company's stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.